Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cancer Journal (Sudbury, Mass.)|July 24, 2026
The Quest to Cure Metastatic Non-Small Cell Lung Cancer With ImmunotherapyDaniel Boiarsky, Natalie Vokes
Medicine|May 31, 2019
Post-stroke rehabilitation: Factors predicting discharge to acute versus subacute rehabilitation facilitiesNeal Rakesh, Daniel Boiarsky, Ammar Athar, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|October 15, 2024
Overcoming EGFR-TKI resistance by targeting the tumor microenvironmentJinsong Zhang, Natalie Vokes, Man Li, et al.
Clinical Lung Cancer|July 20, 2026
Accelerating Lung Cancer Management Through Previsit Liquid Biopsy: Results From the LUNG-FAST Pilot StudyEric K Singhi, Natalie Sanchez, Natalie Vokes, et al.
The Prostate|September 10, 2024
A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancerDaniel Boiarsky, Alok K Tewari, Doga C Gulhan, et al.
Clinical Genitourinary Cancer|February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate CancerDaniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
NPJ Precision Oncology|February 4, 2026
The next layer: augmenting foundation models with structure-preserving and attention-guided learning for local patches to global context awareness in computational pathologyMuhammad Waqas, Rukhmini Bandyopadhyay, Eman Showkatian, et al.
Journal for Immunotherapy of Cancer|December 25, 2024
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLCMehmet Altan, Ruoxing Li, Ziyi Li, et al.
Nature Genetics|November 24, 2020
Integrated molecular drivers coordinate biological and clinical states in melanomaJake R Conway, Felix Dietlein, Amaro Taylor-Weiner, et al.
JCO Precision Oncology|September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate CancerJacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Pageof 4